Chromadex Corp Performance
| CDXCDelisted Stock | USD 7.74 0.13 1.65% |
On a scale of 0 to 100, Chromadex Corp holds a performance score of 8. The firm shows a Beta (market volatility) of 2.36, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chromadex Corp will likely underperform. Please check Chromadex Corp's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Chromadex Corp's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Chromadex Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Chromadex Corp exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Disposition of 82734 shares by Lee Jeong James of Chromadex Corp at 1.52 subject to Rule 16b-3 | 01/17/2025 |
2 | Acquisition by Patrick Kristin of 20000 shares of Chromadex Corp at 1.67 subject to Rule 16b-3 | 02/28/2025 |
3 | Insider Trading | 03/05/2025 |
4 | Acquisition by Carlos Lopez of 273 shares of Chromadex Corp at 7.86 subject to Rule 16b-3 | 03/07/2025 |
5 | ChromaDex changes its corporate name to Niagen Bioscience | 03/13/2025 |
| Begin Period Cash Flow | 27.3 M |
Chromadex |
Chromadex Corp Relative Risk vs. Return Landscape
If you would invest 549.00 in Chromadex Corp on December 20, 2024 and sell it today you would earn a total of 225.00 from holding Chromadex Corp or generate 40.98% return on investment over 90 days. Chromadex Corp is currently generating 0.7836% in daily expected returns and assumes 7.3572% risk (volatility on return distribution) over the 90 days horizon. In different words, 65% of stocks are less volatile than Chromadex, and 85% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Chromadex Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chromadex Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chromadex Corp, and traders can use it to determine the average amount a Chromadex Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1065
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDXC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.36 actual daily | 65 65% of assets are less volatile |
Expected Return
| 0.78 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Chromadex Corp is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chromadex Corp by adding it to a well-diversified portfolio.
Chromadex Corp Fundamentals Growth
Chromadex Stock prices reflect investors' perceptions of the future prospects and financial health of Chromadex Corp, and Chromadex Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chromadex Stock performance.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0784 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 567.71 M | ||||
| Shares Outstanding | 77.75 M | ||||
| Price To Earning | (19.51) X | ||||
| Price To Book | 13.22 X | ||||
| Price To Sales | 6.20 X | ||||
| Revenue | 61.59 M | ||||
| EBITDA | 7.73 M | ||||
| Cash And Equivalents | 16.87 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 2.65 M | ||||
| Debt To Equity | 0.22 % | ||||
| Book Value Per Share | 0.59 X | ||||
| Cash Flow From Operations | 12.11 M | ||||
| Earnings Per Share | 0.11 X | ||||
| Total Asset | 68.28 M | ||||
| Retained Earnings | (181.91 M) | ||||
| Current Asset | 16.55 M | ||||
| Current Liabilities | 9.59 M | ||||
About Chromadex Corp Performance
By analyzing Chromadex Corp's fundamental ratios, stakeholders can gain valuable insights into Chromadex Corp's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chromadex Corp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chromadex Corp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. ChromaDex Corporation is headquartered in Los Angeles, California. Chromadex Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 115 people.Things to note about Chromadex Corp performance evaluation
Checking the ongoing alerts about Chromadex Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chromadex Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chromadex Corp is now traded under the symbol NAGE. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Chromadex Corp is way too risky over 90 days horizon | |
| Chromadex Corp appears to be risky and price may revert if volatility continues | |
| Chromadex Corp has a very high chance of going through financial distress in the upcoming years | |
| About 35.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
- Analyzing Chromadex Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chromadex Corp's stock is overvalued or undervalued compared to its peers.
- Examining Chromadex Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chromadex Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chromadex Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chromadex Corp's stock. These opinions can provide insight into Chromadex Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Chromadex Stock
If you are still planning to invest in Chromadex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromadex Corp's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |